--:--:--
Stockwatch Reports
…

News Reports / Healthcare / ATR

ATRAptarGroup, Inc.

NYSE · Healthcare · Mkt cap $8.7B · Avg vol 454.75K

$137.29

+6.65 (+5.09%)

Quote as of October 30, 2026, 2:23 PM ET

News Impact Report · Published October 30, 2026, 10:11 AM ET

ATR: AptarGroup Posts Q3 FY2026 Net Income of $318.4M, Diluted EPS of $4.75

Share

What Happened

AptarGroup, Inc. filed an 8-K with the SEC on October 29, 2026, disclosing its financial results for the third quarter of fiscal year 2026 (Items 2.02 and 9.01). The company reported revenues of $2.81 billion for Q3 FY2026, alongside net income of $318.4 million and operating income of $394.8 million. Diluted earnings per share came in at $4.75, with basic EPS at $4.83 for the quarter.

Why It Matters

For investors, these results offer a concrete snapshot of AptarGroup's current earnings power. The gap between operating income ($394.8M) and net income ($318.4M) is worth noting, as it reflects the costs — including interest, taxes, and other below-the-line items — absorbed between the two lines. On a full-year basis, the company's prior fiscal year (FY2025) saw revenues of approximately $3.49 billion, providing a useful baseline against which the Q3 FY2026 revenue run-rate can be compared. The stock is trading at $139.34, up 6.66% on the day of this report, suggesting the market is responding positively to the disclosed figures. StockWatch published its Initiating Coverage on AptarGroup on October 30, 2026 — readers can refer to that report for deeper context on the company's longer-term positioning.

Analysis

AptarGroup's Q3 FY2026 results present a picture of a business generating meaningful profitability. The operating margin implied by the reported figures — operating income of $394.8 million against revenues of $2.81 billion — points to an operating margin of roughly 14% for the quarter, which is a reasonable benchmark for a specialty packaging and dispensing-solutions company with AptarGroup's profile.

The single-day stock move of nearly 7% indicates that either these results beat prevailing market expectations or that the guidance or commentary accompanying the filing resonated positively with investors — though the specific forward guidance language is not captured in the structured XBRL data provided. Investors should review the full earnings release and any accompanying management commentary filed as exhibits for a complete picture.

Key things to watch going forward:

  • Revenue trajectory: Whether Q3's pace is consistent with achieving FY2026 full-year revenue growth relative to FY2025's $3.49 billion baseline.
  • Margin sustainability: How operating and net margins evolve as input costs and foreign exchange effects play out through the remainder of the fiscal year.
  • Capital allocation signals: Any commentary on dividends, buybacks, or M&A included in the supplementary materials attached to this 8-K.

Disclaimer

This report is a news and informational summary based solely on data contained in AptarGroup's SEC filing and publicly available market data. It does not constitute investment advice, and no Buy, Hold, or Sell rating or price target is issued or implied herein. Investors should conduct their own due diligence before making any investment decisions.

Existing Coverage

StockWatch has full coverage on ATR, published 2026-10-30. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-29. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/896622/000089662226000187/atr-20261029.htm

StockWatch initiated coverage · October 30, 2026

ATR: AptarGroup's Pharma Dispensing and Closures Franchise

Valuation reset, not a fundamentals break: At $141.45 the shares trade at roughly 25.5x trailing EPS of $5.54 and 1.5x sales on an $8.9B market cap, near the top of a 52-week range of $103.23–$146.91. The 8.13% single-day move on light 60,635-share volume signals a news-driven re-rating rather than a broad institutional accumulation cycle.

-2.9%

Read the full report →

-2.9%

Key Data

Last

$139.34

P&L ($)

+$8.70

P&L (%)

+6.66%

Day Range

$135.85 - $142.31

Volume

101.19K

Market Cap

$8.7B

Previous Close

$130.64

Open

$138.59

52 Week Range

$103.23 - $146.91

Shares Outstanding

63.58M

Public Float

62.97M

Average Volume

454.75K

As of October 30, 2026, 11:16 AM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc